First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized TrialCesare Gridelli, Francesco Perrone, Fortunato Ciardiello et al.|Journal of Clinical Oncology|2012Cited by 234
Loss of Phosphatase and Tensin Homolog Protein Expression Is an Independent Poor Prognostic Marker in Lung AdenocarcinomaNaoki Yanagawa, Ming‐Sound Tsao, Mauro Saieg et al.|Journal of Thoracic Oncology|2012Cited by 56